Skip to search formSkip to main contentSkip to account menu

maltose tetrapalmitate

Known as: D-Glucose, 4-O-alpha-D-glucopyranosyl-, tetrahexadecanoate, maltose tetrapalmitate (MTP) 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Glycolipids

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1994
Review
1994
Angiogenesis and breast cancer.
  • D. Hayes
  • Hematology/oncology clinics of North America
  • 1994
  • Corpus ID: 23686878
1993
1993
The effect of maltose tetrapalmitate (MTP) on prostate cancer growth in vivo and in vitro.
Maltose tetrapalmitate (MTP), a non-toxic synthetic glycolipid analog of lipid A, has been shown to have antitumor activity in… 
1989
1989
Evaluation of cortisone-heparin and cortisone-maltose tetrapalmitate therapies against rodent tumors. I. Biological studies.
The antitumor activity of either cortisone-heparin or cortisone-maltose tetrapalmitate combination or both was tested against two… 
1989
1989
Evaluation of cortisone-heparin and cortisone-maltose tetrapalmitate therapies against rodent tumors. II. Pathological studies.
Pathological studies were undertaken in three tumor-host models which were subjected to cortisone based treatments. The first… 
1988
1988
Antitumor efficacies of maltose tetrapalmitate immunotherapy alone and in combinations with radiotherapy and with cyclophosphamide chemotherapy against dimethylhydrazine induced colon and anal…
Treatment of human colonic cancer in early stages when the process is still limited to the colonic wall is primarily surgery. We… 
1988
1988
Prophylactic maltose tetrapalmitate and bacillus Calmette-Guerin immunotherapy of recurrent superficial bladder tumors: preliminary report.
1986
1986
Combined radiotherapy, chemotherapy, and maltose tetrapalmitate immunotherapy in the treatment of 4'dimethylaminoazobenzene-induced liver cancer.
Therapeutic effects of radiotherapy (R), chemotherapy, and maltose tetrapalmitate (MTP) immunotherapy alone and in combinations… 
1984
1984
Combined cyclophosphamide chemotherapy and maltose tetrapalmitate immunotherapy in the treatment of transplanted bladder and prostate carcinoma of the rat.
Chemoimmunotherapy in two animal models for urological cancers was studied. The models were Dunning R3327A prostatic carcinoma… 
1983
1983
A comparative study of the intravesical MTP and BCG treatment of transplantable bladder cancer.
1980
1980
The antitumour activity of maltose tetrapalmitate compared with other immunoadjuvants, and its effectiveness after tumour surgery.
The effectivenss of maltose tetrapalmitate (MTP) as an antitumour immune adjuvant was verified by its comparison with other known… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)